Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Byte Acquisition Corp Cl A (NQ: BYTS ) N/A UNCHANGED Last Price Updated: 3:59 PM EST, Dec 21, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Byte Acquisition Corp Cl A Airship AI Makes Its Debut On The Nasdaq After Completing Merger With BYTE Acquisition Corp. December 28, 2023 --News Direct-- Via News Direct Topics Artificial Intelligence Exposures Artificial Intelligence Airship AI Makes Its Debut On The Nasdaq After Completing Merger With BYTE Acquisition Corp. December 27, 2023 Airship AI (NASDAQ: AISP), the Redmond, Washington artificial intelligence company helping U.S. Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 21, 2023 Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. Via Benzinga Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket December 19, 2023 Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering. Motus GI Holdings shares dipped 46.5% to $1.15 in... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday December 19, 2023 It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning! Via InvestorPlace Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket December 18, 2023 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in... Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
